Advances in sickle cell therapies in the hydroxyurea era.

Field, Joshua J; Nathan, David G

Field, Joshua J; Nathan, David G.

Affiliation

Field JJ; Medical Sciences Institute, BloodCenter of Wisconsin, Milwaukee, Wisconsin, United States of America Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.
Nathan DG; Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America Boston Children's Hospital, Boston, Massachusetts, United States of America Harvard Medical School, Boston, Massachusetts, United States of America.

Mol Med ; 20 Suppl 1: S37-42, 2014 Dec 16.

Article in En | MEDLINE | ID: mdl-25549232

Subject(s)

Anemia, Sickle Cell/therapy; Animals; Cell Adhesion/drug effects; Genetic Therapy; Hematopoietic Stem Cell Transplantation; Hemolysis/drug effects; Humans; Hydroxyurea/therapeutic use; Inflammation/therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anemia, Sickle Cell Limits: Animals / Humans Language: En Journal: Mol Med Journal subject: BIOLOGIA MOLECULAR Year: 2014 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google